GZMB antibody (AA 73-187)
Quick Overview for GZMB antibody (AA 73-187) (ABIN6294582)
Target
See all GZMB AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 73-187
-
Purpose
- Rabbit anti-Human Granzyme B Antibody [Sodium Azide Free]
-
Specificity
- Cytoplasmic
-
Purification
- A recombinant fragment (amino acids 73-187) from the human protein was used as the immunogen for the Granzyme B antibody.
-
Immunogen
- A recombinant fragment (amino acids 73-187) from the human protein was used as the immunogen for the Granzyme B antibody.
-
-
-
-
Application Notes
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 0.5-1 μg/mL
Western blot: 1-2 μg/mL
Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1) -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- GZMB (Granzyme B (GZMB))
-
Alternative Name
- Granzyme B
-
Background
-
Target Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'non-self' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease.
Gene Symbol: GZMB///CGL1///CSPB///CTLA1///GRB
-
Gene ID
- 3002
-
UniProt
- P10144
-
Pathways
- Apoptosis, Caspase Cascade in Apoptosis
Target
-